All Companies
LLYCongressional Stock Trades
Eli Lilly & Co.
Pharmaceutical Preparations
Congressional stock trades in Eli Lilly & Co. (LLY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
53
Politicians Trading
22
Last Traded
Jul 10, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Michael A. RulliR | Aug 7, 2026 | Jul 1, 2026 | Sell | $1,001 - $15,000 | -3.26% |
| Michael A. RulliR | Aug 7, 2026 | Dec 2, 2025 | Sell | $1,001 - $15,000 | +10.21% |
| Dan NewhouseR | Jul 17, 2026 | Jul 10, 2026 | Sell | $1,001 - $15,000 | -3.00% |
| David TaylorR | Feb 20, 2026 | Feb 9, 2026 | Sell | $1,001 - $15,000 | +10.36% |
| David TaylorR | Feb 2, 2026 | Jan 16, 2026 | Sell | $1,001 - $15,000 | +11.03% |
| David TaylorR | Dec 19, 2025 | Dec 10, 2025 | Sell | $1,001 - $15,000 | +16.03% |
| Lisa C. McClainR | Aug 13, 2025 | Jul 16, 2025 | Sell | $1,001 - $15,000 | +45.98% |
| Lisa C. McClainR | Aug 13, 2025 | Jun 9, 2025 | Sell | $1,001 - $15,000 | +49.01% |
| Jefferson ShreveR | Jun 22, 2025 | May 12, 2025 | Sell | $100,001 - $250,000 | +52.59% |
| Dan NewhouseR | May 16, 2025 | Apr 11, 2025 | Sell | $1,001 - $15,000 | +57.42% |
| Bruce WestermanR | May 12, 2025 | Apr 21, 2025 | Sell | $1,001 - $15,000 | +40.94% |
| Robert BresnahanR | Apr 28, 2025 | Apr 8, 2025 | Sell | $1,001 - $15,000 | +58.75% |
Price History
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.